ARTICLE | Clinical News
Genesis, SR Pharma start Phase II eczema trial
September 10, 2003 7:00 AM UTC
Genesis Research (ASE:GEN) and SR Pharma (LSE:SPA) started a placebo-controlled New Zealand Phase II trial of AVAC to treat pediatric atopic dermatitis in 120 children ages 5-16. The primary endpoint ...